| Website | oncohealthcorp.com |
| Category | BioTech |
| Employees | |
| Description | Medical Diagnostics |
| TOTAL | $2.85M |
| FUNDING TOTAL | $2.85M |
| Angel, 1/11 David Wu Band of Angels Life Science Angels | $1.25M |
| Series A, 5/11 Sand Hill Angels Life Science Angels | $1.6M |
OncoHealth Corporation plans to commercialize novel, proprietary screening and diagnostic tests for cervical cancer and other cancers associated with the human papillomavirus. The company’s technology platform includes proprietary biomarkers and robust detection technology that can enable the development of easy-to-use, high-throughput and cost-competitive assays.
